Health innovation networks to help developing countries address neglected diseases

Science. 2005 Jul 15;309(5733):401-4. doi: 10.1126/science.1115538.

Abstract

Gross inequities in disease burden between developed and developing countries are now the subject of intense global attention. Public and private donors have marshaled resources and created organizational structures to accelerate the development of new health products and to procure and distribute drugs and vaccines for the poor. Despite these encouraging efforts directed primarily from and funded by industrialized countries, sufficiency and sustainability remain enormous challenges because of the sheer magnitude of the problem. Here we highlight a complementary and increasingly important means to improve health equity: the growing ability of some developing countries to undertake health innovation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomedical Research* / economics
  • Biotechnology
  • Delivery of Health Care* / organization & administration
  • Developed Countries
  • Developing Countries*
  • Diffusion of Innovation*
  • Drug Industry
  • Health Policy
  • Humans
  • International Cooperation
  • Patents as Topic
  • Private Sector
  • Public Sector
  • Publishing
  • Technology Transfer